Press Release
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
September 15, 2024
Read MoreFrom precision diagnostics to radiopharmaceuticals—we pioneer next-generation solutions that help improve outcomes and lives.
It’s our purpose. Our passion. Making a difference in the lives of patients. Because we never forget that someone’s health is in our hands.
Press Release
September 15, 2024
Read MorePress Release
September 5, 2024
Read MorePress Release
August 28, 2024
Read MoreData provided by Nasdaq. Minimum 15 minutes delayed.
Looking to make a change that makes a difference? Our work at Lantheus puts patients first. Our innovations help clinicians Find, Fight and Follow® disease so that patients can achieve better outcomes. Take the first step in a new direction today.